Caption Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Caption Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-210,000	Closed	-$1.83M	–	1335
2024 Q1	$1.83M	Buy	210,000 +150,000	+250%	+$1.82M	0.03%	558
2023 Q4	$686K	Buy	+60,000	New	+$593K	0.01%	885
2021 Q4	–	Sell	-40,000	Closed	-$522K	–	1759
2021 Q3	$522K	Buy	+40,000	New	+$517K	0.01%	1194
2021 Q2	–	Sell	-142,800	Closed	-$1.6M	–	1432
2021 Q1	$1.6M	Buy	+142,800	New	+$1.51M	0.03%	572
2020 Q1	–	Sell	-35,000	Closed	-$466K	–	965
2019 Q4	$466K	Hold	35,000	–	–	0.02%	639
2019 Q3	$301K	Buy	+35,000	New	+$340K	0.02%	552

Other funds holding IRWD

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Caption Management's IRWD Position: Q1 2025 in Review

Caption Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 50,000 shares — an estimated $222K sold.

Caption Management first reported a position in IRWD in Q4 2018 and held it in 13 quarters. The position peaked at $2.27M in Q2 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

Caption Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Caption Management sold 50,000 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $222K.
Caption Management first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 13 quarters.
Caption Management's Ironwood Pharmaceuticals position peaked at $2.27M in Q2 2021.
200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.